Mitofusin-2 is a novel direct target of p53

Biochemical and Biophysical Research Communications

Volumn 400, Issue 4, 2010, Pages 587-592

  Wang, Weilin ^a   Cheng, Xiaofei ^a   Lu, Jianju ^a   Wei, Jianfeng ^a   Fu, Guanghou ^a   Zhu, Feng ^a   Jia, Changku ^a   Zhou, Lin ^a   Xie, Haiyang ^a   Zheng, Shusen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chromatin immunoprecipitation; Mfn2; P53; Promoter; Transcription

Indexed keywords

LUCIFERASE; MESSENGER RNA; MITOFUSIN 2; PROTEIN P53;

APOPTOSIS; ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTROSPECTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE; UPREGULATION; WILD TYPE;

BASE SEQUENCE; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77957270300     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.108     Document Type: Article

References (27)

1. Chen K.H., Guo X., Ma D., Guo Y., Li Q., Yang D., Li P., Qiu X., Wen S., Xiao R.P., Tang J. Dysregulation of HSG triggers vascular proliferative disorders. Nat. Cell Biol. 2004, 6:872-883.
2. Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., Chan D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 2003, 160:189-200.
3. Guo X., Chen K.H., Guo Y., Liao H., Tang J., Xiao R.P. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ. Res. 2007, 101:1113-1122.
4. Karbowski M., Lee Y.J., Gaume B., Jeong S.Y., Frank S., Nechushtan A., Santel A., Fuller M., Smith C.L., Youle R.J. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 2002, 159:931-938.
5. Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J., Daugaard J.R., Lloberas J., Camps M., Zierath J.R., Rabasa-Lhoret R., Wallberg-Henriksson H., Laville M., Palacin M., Vidal H., Rivera F., Brand M., Zorzano A. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 2003, 278:17190-17197.
6. Soriano F.X., Liesa M., Bach D., Chan D.C., Palacin M., Zorzano A. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes 2006, 55:1783-1791.
7. Li Y., Yin R., Liu J., Wang P., Wu S., Luo J., Zhelyabovska O., Yang Q. Peroxisome proliferator-activated receptor delta regulates mitofusin 2 expression in the heart. J. Mol. Cell. Cardiol. 2009, 46:876-882.
8. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
9. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
10. el-Deiry W.S. Regulation of p53 downstream genes. Semin. Cancer Biol. 1998, 8:345-357.
11. Ko L.J., Prives C. P53: puzzle and paradigm. Genes Dev. 1996, 10:1054-1072.
12. el-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1992, 1:45-49.
13. Wang W.L., Zhu F., Wang S.Q., Wei J.F., Jia C.K., Zhang Y.B., Zhou L., Xie H.Y., Zheng S.S. HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo. Oncol. Rep. 2010, 24:183-188.
14. Bourdon J.C., DeguinChambon V., Lelong J.C., Dessen P., May P., Debuire B., May E. Further characterisation of the p53 responsive element - identification of new candidate genes for trans-activation by p53. Oncogene 1997, 14:85-94.
15. Tondera D., Czauderna F., Paulick K., Schwarzer R., Kaufmann J., Santel A. The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells. J. Cell Sci. 2005, 118:3049-3059.
16. Ishihara N., Eura Y., Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J. Cell Sci. 2004, 117:6535-6546.
17. Santel A., Fuller M.T. Control of mitochondrial morphology by a human mitofusin. J. Cell Sci. 2001, 114:867-874.
18. Rojo M., Legros F., Chateau D., Lombes A. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci. 2002, 115:1663-1674.
19. Simon D., Knowles B.B., Weith A. Abnormalities of chromosome-1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 1991, 6:765-770.
20. Sun M., Eshleman J.R., Ferrell L.D., Jacobs G., Sudilovsky E.C., Tuthill R., Hussein M.R., Sudilovsky O. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region. Hepatology 2001, 33:1415-1424.
21. Wu L., Li Z., Zhang Y., Zhang P., Zhu X., Huang J., Ma T., Lu T., Song Q., Li Q., Guo Y., Tang J., Ma D., Chen K.H., Qiu X. Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells. Mol. Cancer Ther. 2008, 7:222-232.
22. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. P53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
23. Johnstone R.W., Ruefli A.A., Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002, 108:153-164.
24. Levine A.J., Hu W., Feng Z. The P53 pathway: what questions remain to be explored?. Cell Death Differ. 2006, 13:1027-1036.
25. Resnick M.A., Tomso D., Inga A., Menendez D., Bell D. Functional diversity in the gene network controlled by the master regulator p53 in humans. Cell Cycle 2005, 4:1026-1029.
26. Goldsmith M.E., Gudas J.M., Schneider E., Cowan K.H. Wild-type p53 stimulates expression from the human multidrug-resistance promoter in a p53-negative cell-line. J. Biol. Chem. 1995, 270:1894-1898.
27. Liu G., Chen X.B. DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation (vol. 26, p. 1398, 2006). Mol. Cell. Biol. 2006, 26:3680.